Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion
Total coronary artery occlusion and reperfusion result in attenuation of coronary blood flow reserve, regional myocardial dysfunction, and myocardial leukocyte infiltration. To examine the effects of intracoronary adenosine on these occlusion and reperfusion-induced perturbations, we subjected 14 do...
Gespeichert in:
Veröffentlicht in: | The American heart journal 1994-05, Vol.127 (5), p.1201-1211 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1211 |
---|---|
container_issue | 5 |
container_start_page | 1201 |
container_title | The American heart journal |
container_volume | 127 |
creator | Nichols, W.W. Nicolini, F.A. Yang, B.C. Henson, K. Stechmiller, J.K. Mehta, J.L. |
description | Total coronary artery occlusion and reperfusion result in attenuation of coronary blood flow reserve, regional myocardial dysfunction, and myocardial leukocyte infiltration. To examine the effects of intracoronary adenosine on these occlusion and reperfusion-induced perturbations, we subjected 14 dogs to total left anterior descending (LAD) coronary artery occlusion (1 hour) and reperfusion (1 hour). Seven dogs received adenosine (3.75 mg/min into the LAD distal to the occlusion) over a 1-hour period starting 5 minutes before reperfusion, and the remaining seven dogs received saline solution. One dog in each group died of ventricular fibrillation during coronary artery occlusion. Coronary flow reserve, measured as peak reactive hyperemia (10 and 20 seconds of total coronary artery occlusion) and peak coronary blood flow response to acetylcholine (0.01 to 1.0 μg) and nitroglycerin (5 to 25 μg), was impaired in the LAD region after LAD occlusion and reperfusion in the saline-treated dogs (all
p < 0.01 vs before occlusion and reperfusion); LAD regional myocardial shortening fraction measured by ultrasonic crystals was also diminished after occlusion and reperfusion in saline-treated dogs (−5% ± 1% vs 12% ± 2%;
p < 0.02). The adenosine-treated dogs showed total protection against loss of coronary flow reserve (peak reactive hyperemia and blood flow increase in response to acetylcholine and nitroglycerin; all
p values not significant vs before LAD occlusion and reperfusion). LAD regional myocardial shortening fraction was also preserved in adenosine-treated dogs (9% ± 2% vs 14% ± 2%;
p not significant). Myocardial myeloperoxidase activity, measured as an index of myocardial leukocyte infiltration, was greater (
p < 0.02) in the LAD ischemic-reperfused regions than in nonischemic circumflex regions in the saline-treated dogs. A similar difference in myeloperoxidase activities in the reperfused and control regions was not observed in the adenosine-treated dogs. Thus adenosine protects against loss of coronary flow reserve and regional myocardial function in dogs subjected to coronary artery occlusion and reperfusion. |
doi_str_mv | 10.1016/0002-8703(94)90037-X |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76469874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000287039490037X</els_id><sourcerecordid>76469874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-f1c6a42b798671c67713934311d2be60634f89bef7d3487875761f3ca2b19c183</originalsourceid><addsrcrecordid>eNp9kUlrHDEQhUVIsMfLP4hBh2DsQydSS9ZyMRjjDQy5JOCbUKtLQaFHmkhqG_97axbmmJNUvO8VVa8Q-krJd0qo-EEI6TslCbvQ_FITwmT38gktKNGyE5Lzz2ixRw7RUSl_Wyl6JQ7QgaKyJ1wu0NvNCDGVEAGvcqrgasH2jw2xVGxrhTjbGlLEyWM_pTecoUB-BWzjiJfvydk8BjthP0e34ayvkLFLOUWb33FybprLRmiGDCvIflOfoC_eTgVOd-8x-n1_9-v2sXv--fB0e_PcOaZE7Tx1wvJ-kFoJ2f5SUqYZZ5SO_QCCCMa90gN4OTKupJJXUlDPnO0Hqh1V7Bidb_u27f7NUKpZhuJgmmyENBcjBRdaSd5AvgVdTqVk8GaVw7LtYCgx67zNOkyzDtNobjZ5m5dmO9v1n4cljHvTLuCmf9vptjg7-WyjC2WPccqu2swNu95i0LJ4DZBNcQGigzHkdhMzpvD_OT4Ae4id8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76469874</pqid></control><display><type>article</type><title>Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Nichols, W.W. ; Nicolini, F.A. ; Yang, B.C. ; Henson, K. ; Stechmiller, J.K. ; Mehta, J.L.</creator><creatorcontrib>Nichols, W.W. ; Nicolini, F.A. ; Yang, B.C. ; Henson, K. ; Stechmiller, J.K. ; Mehta, J.L.</creatorcontrib><description>Total coronary artery occlusion and reperfusion result in attenuation of coronary blood flow reserve, regional myocardial dysfunction, and myocardial leukocyte infiltration. To examine the effects of intracoronary adenosine on these occlusion and reperfusion-induced perturbations, we subjected 14 dogs to total left anterior descending (LAD) coronary artery occlusion (1 hour) and reperfusion (1 hour). Seven dogs received adenosine (3.75 mg/min into the LAD distal to the occlusion) over a 1-hour period starting 5 minutes before reperfusion, and the remaining seven dogs received saline solution. One dog in each group died of ventricular fibrillation during coronary artery occlusion. Coronary flow reserve, measured as peak reactive hyperemia (10 and 20 seconds of total coronary artery occlusion) and peak coronary blood flow response to acetylcholine (0.01 to 1.0 μg) and nitroglycerin (5 to 25 μg), was impaired in the LAD region after LAD occlusion and reperfusion in the saline-treated dogs (all
p < 0.01 vs before occlusion and reperfusion); LAD regional myocardial shortening fraction measured by ultrasonic crystals was also diminished after occlusion and reperfusion in saline-treated dogs (−5% ± 1% vs 12% ± 2%;
p < 0.02). The adenosine-treated dogs showed total protection against loss of coronary flow reserve (peak reactive hyperemia and blood flow increase in response to acetylcholine and nitroglycerin; all
p values not significant vs before LAD occlusion and reperfusion). LAD regional myocardial shortening fraction was also preserved in adenosine-treated dogs (9% ± 2% vs 14% ± 2%;
p not significant). Myocardial myeloperoxidase activity, measured as an index of myocardial leukocyte infiltration, was greater (
p < 0.02) in the LAD ischemic-reperfused regions than in nonischemic circumflex regions in the saline-treated dogs. A similar difference in myeloperoxidase activities in the reperfused and control regions was not observed in the adenosine-treated dogs. Thus adenosine protects against loss of coronary flow reserve and regional myocardial function in dogs subjected to coronary artery occlusion and reperfusion.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/0002-8703(94)90037-X</identifier><identifier>PMID: 8172047</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Acetylcholine - pharmacology ; Adenosine - administration & dosage ; Adenosine - pharmacology ; Animals ; Antianginal agents. Coronary vasodilator agents ; Biological and medical sciences ; Cardiovascular system ; Coronary Circulation - drug effects ; Coronary Disease - physiopathology ; Coronary Vessels ; Dogs ; Female ; Heart - drug effects ; Heart - physiology ; Hemodynamics - drug effects ; Infusions, Intra-Arterial ; Male ; Medical sciences ; Myocardial Reperfusion Injury - physiopathology ; Myocardium - enzymology ; Nitroglycerin - pharmacology ; Peroxidase - analysis ; Peroxidase - drug effects ; Pharmacology. Drug treatments ; Random Allocation</subject><ispartof>The American heart journal, 1994-05, Vol.127 (5), p.1201-1211</ispartof><rights>1994</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-f1c6a42b798671c67713934311d2be60634f89bef7d3487875761f3ca2b19c183</citedby><cites>FETCH-LOGICAL-c386t-f1c6a42b798671c67713934311d2be60634f89bef7d3487875761f3ca2b19c183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/000287039490037X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4135757$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8172047$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nichols, W.W.</creatorcontrib><creatorcontrib>Nicolini, F.A.</creatorcontrib><creatorcontrib>Yang, B.C.</creatorcontrib><creatorcontrib>Henson, K.</creatorcontrib><creatorcontrib>Stechmiller, J.K.</creatorcontrib><creatorcontrib>Mehta, J.L.</creatorcontrib><title>Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Total coronary artery occlusion and reperfusion result in attenuation of coronary blood flow reserve, regional myocardial dysfunction, and myocardial leukocyte infiltration. To examine the effects of intracoronary adenosine on these occlusion and reperfusion-induced perturbations, we subjected 14 dogs to total left anterior descending (LAD) coronary artery occlusion (1 hour) and reperfusion (1 hour). Seven dogs received adenosine (3.75 mg/min into the LAD distal to the occlusion) over a 1-hour period starting 5 minutes before reperfusion, and the remaining seven dogs received saline solution. One dog in each group died of ventricular fibrillation during coronary artery occlusion. Coronary flow reserve, measured as peak reactive hyperemia (10 and 20 seconds of total coronary artery occlusion) and peak coronary blood flow response to acetylcholine (0.01 to 1.0 μg) and nitroglycerin (5 to 25 μg), was impaired in the LAD region after LAD occlusion and reperfusion in the saline-treated dogs (all
p < 0.01 vs before occlusion and reperfusion); LAD regional myocardial shortening fraction measured by ultrasonic crystals was also diminished after occlusion and reperfusion in saline-treated dogs (−5% ± 1% vs 12% ± 2%;
p < 0.02). The adenosine-treated dogs showed total protection against loss of coronary flow reserve (peak reactive hyperemia and blood flow increase in response to acetylcholine and nitroglycerin; all
p values not significant vs before LAD occlusion and reperfusion). LAD regional myocardial shortening fraction was also preserved in adenosine-treated dogs (9% ± 2% vs 14% ± 2%;
p not significant). Myocardial myeloperoxidase activity, measured as an index of myocardial leukocyte infiltration, was greater (
p < 0.02) in the LAD ischemic-reperfused regions than in nonischemic circumflex regions in the saline-treated dogs. A similar difference in myeloperoxidase activities in the reperfused and control regions was not observed in the adenosine-treated dogs. Thus adenosine protects against loss of coronary flow reserve and regional myocardial function in dogs subjected to coronary artery occlusion and reperfusion.</description><subject>Acetylcholine - pharmacology</subject><subject>Adenosine - administration & dosage</subject><subject>Adenosine - pharmacology</subject><subject>Animals</subject><subject>Antianginal agents. Coronary vasodilator agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Coronary Circulation - drug effects</subject><subject>Coronary Disease - physiopathology</subject><subject>Coronary Vessels</subject><subject>Dogs</subject><subject>Female</subject><subject>Heart - drug effects</subject><subject>Heart - physiology</subject><subject>Hemodynamics - drug effects</subject><subject>Infusions, Intra-Arterial</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocardial Reperfusion Injury - physiopathology</subject><subject>Myocardium - enzymology</subject><subject>Nitroglycerin - pharmacology</subject><subject>Peroxidase - analysis</subject><subject>Peroxidase - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Random Allocation</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUlrHDEQhUVIsMfLP4hBh2DsQydSS9ZyMRjjDQy5JOCbUKtLQaFHmkhqG_97axbmmJNUvO8VVa8Q-krJd0qo-EEI6TslCbvQ_FITwmT38gktKNGyE5Lzz2ixRw7RUSl_Wyl6JQ7QgaKyJ1wu0NvNCDGVEAGvcqrgasH2jw2xVGxrhTjbGlLEyWM_pTecoUB-BWzjiJfvydk8BjthP0e34ayvkLFLOUWb33FybprLRmiGDCvIflOfoC_eTgVOd-8x-n1_9-v2sXv--fB0e_PcOaZE7Tx1wvJ-kFoJ2f5SUqYZZ5SO_QCCCMa90gN4OTKupJJXUlDPnO0Hqh1V7Bidb_u27f7NUKpZhuJgmmyENBcjBRdaSd5AvgVdTqVk8GaVw7LtYCgx67zNOkyzDtNobjZ5m5dmO9v1n4cljHvTLuCmf9vptjg7-WyjC2WPccqu2swNu95i0LJ4DZBNcQGigzHkdhMzpvD_OT4Ae4id8w</recordid><startdate>19940501</startdate><enddate>19940501</enddate><creator>Nichols, W.W.</creator><creator>Nicolini, F.A.</creator><creator>Yang, B.C.</creator><creator>Henson, K.</creator><creator>Stechmiller, J.K.</creator><creator>Mehta, J.L.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940501</creationdate><title>Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion</title><author>Nichols, W.W. ; Nicolini, F.A. ; Yang, B.C. ; Henson, K. ; Stechmiller, J.K. ; Mehta, J.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-f1c6a42b798671c67713934311d2be60634f89bef7d3487875761f3ca2b19c183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Acetylcholine - pharmacology</topic><topic>Adenosine - administration & dosage</topic><topic>Adenosine - pharmacology</topic><topic>Animals</topic><topic>Antianginal agents. Coronary vasodilator agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Coronary Circulation - drug effects</topic><topic>Coronary Disease - physiopathology</topic><topic>Coronary Vessels</topic><topic>Dogs</topic><topic>Female</topic><topic>Heart - drug effects</topic><topic>Heart - physiology</topic><topic>Hemodynamics - drug effects</topic><topic>Infusions, Intra-Arterial</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocardial Reperfusion Injury - physiopathology</topic><topic>Myocardium - enzymology</topic><topic>Nitroglycerin - pharmacology</topic><topic>Peroxidase - analysis</topic><topic>Peroxidase - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Random Allocation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nichols, W.W.</creatorcontrib><creatorcontrib>Nicolini, F.A.</creatorcontrib><creatorcontrib>Yang, B.C.</creatorcontrib><creatorcontrib>Henson, K.</creatorcontrib><creatorcontrib>Stechmiller, J.K.</creatorcontrib><creatorcontrib>Mehta, J.L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nichols, W.W.</au><au>Nicolini, F.A.</au><au>Yang, B.C.</au><au>Henson, K.</au><au>Stechmiller, J.K.</au><au>Mehta, J.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>1994-05-01</date><risdate>1994</risdate><volume>127</volume><issue>5</issue><spage>1201</spage><epage>1211</epage><pages>1201-1211</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>Total coronary artery occlusion and reperfusion result in attenuation of coronary blood flow reserve, regional myocardial dysfunction, and myocardial leukocyte infiltration. To examine the effects of intracoronary adenosine on these occlusion and reperfusion-induced perturbations, we subjected 14 dogs to total left anterior descending (LAD) coronary artery occlusion (1 hour) and reperfusion (1 hour). Seven dogs received adenosine (3.75 mg/min into the LAD distal to the occlusion) over a 1-hour period starting 5 minutes before reperfusion, and the remaining seven dogs received saline solution. One dog in each group died of ventricular fibrillation during coronary artery occlusion. Coronary flow reserve, measured as peak reactive hyperemia (10 and 20 seconds of total coronary artery occlusion) and peak coronary blood flow response to acetylcholine (0.01 to 1.0 μg) and nitroglycerin (5 to 25 μg), was impaired in the LAD region after LAD occlusion and reperfusion in the saline-treated dogs (all
p < 0.01 vs before occlusion and reperfusion); LAD regional myocardial shortening fraction measured by ultrasonic crystals was also diminished after occlusion and reperfusion in saline-treated dogs (−5% ± 1% vs 12% ± 2%;
p < 0.02). The adenosine-treated dogs showed total protection against loss of coronary flow reserve (peak reactive hyperemia and blood flow increase in response to acetylcholine and nitroglycerin; all
p values not significant vs before LAD occlusion and reperfusion). LAD regional myocardial shortening fraction was also preserved in adenosine-treated dogs (9% ± 2% vs 14% ± 2%;
p not significant). Myocardial myeloperoxidase activity, measured as an index of myocardial leukocyte infiltration, was greater (
p < 0.02) in the LAD ischemic-reperfused regions than in nonischemic circumflex regions in the saline-treated dogs. A similar difference in myeloperoxidase activities in the reperfused and control regions was not observed in the adenosine-treated dogs. Thus adenosine protects against loss of coronary flow reserve and regional myocardial function in dogs subjected to coronary artery occlusion and reperfusion.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>8172047</pmid><doi>10.1016/0002-8703(94)90037-X</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-8703 |
ispartof | The American heart journal, 1994-05, Vol.127 (5), p.1201-1211 |
issn | 0002-8703 1097-6744 |
language | eng |
recordid | cdi_proquest_miscellaneous_76469874 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acetylcholine - pharmacology Adenosine - administration & dosage Adenosine - pharmacology Animals Antianginal agents. Coronary vasodilator agents Biological and medical sciences Cardiovascular system Coronary Circulation - drug effects Coronary Disease - physiopathology Coronary Vessels Dogs Female Heart - drug effects Heart - physiology Hemodynamics - drug effects Infusions, Intra-Arterial Male Medical sciences Myocardial Reperfusion Injury - physiopathology Myocardium - enzymology Nitroglycerin - pharmacology Peroxidase - analysis Peroxidase - drug effects Pharmacology. Drug treatments Random Allocation |
title | Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A09%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adenosine%20protects%20against%20attenuation%20of%20flow%20reserve%20and%20myocardial%20function%20after%20coronary%20occlusion%20and%20reperfusion&rft.jtitle=The%20American%20heart%20journal&rft.au=Nichols,%20W.W.&rft.date=1994-05-01&rft.volume=127&rft.issue=5&rft.spage=1201&rft.epage=1211&rft.pages=1201-1211&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/0002-8703(94)90037-X&rft_dat=%3Cproquest_cross%3E76469874%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76469874&rft_id=info:pmid/8172047&rft_els_id=000287039490037X&rfr_iscdi=true |